Longevity Health Holdings, Inc. Financial Summary

Quick Answer

Longevity Health Holdings, Inc. reported Total Revenue of $1.91 million for fiscal year 2025.

Longevity Health Holdings, Inc. — Key Financials by Year

Metric 2025 2024 2023 2022 2021
Total Revenue $1.91M
+3701.4%
$50.3K $0.00
Revenue (ASC 606) $1.91M
+3701.4%
$50.3K $0.00
Net Income -$6.91M
+33.4%
-$10.37M
+32.9%
-$15.45M
-70.6%
-$9.05M
-2648.0%
-$329.4K
Diluted EPS -$4.83
+66.8%
-$14.56
-897.3%
-$1.46
+73.3%
-$5.47
Total Assets $2.37M
+60.6%
$1.47M
-97.7%
$63.95M
+3557.3%
$1.75M
-98.9%
$155.42M
Cash and Equivalents $706.7K
+349.8%
$157.1K $0.00
Stockholders Equity -$5.87M
-24.5%
-$4.71M
-119.0%
$24.75M
+165.5%
-$37.79M $0.00
R&D Expense $788.9K
-25.2%
$1.05M
-57.8%
$2.50M
+13.7%
$2.20M
Operating Income -$7.11M
-42.2%
-$5.00M
+15.9%
-$5.94M
-7.9%
-$5.51M
-1078.3%
-$467.4K
Gross Profit $1.09M
+2390.3%
$44.0K $0.00
Shares Outstanding 1.78M
+155.6%
696,969
-96.4%
19.24M
+2045.5%
896,580

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue September 30, 2025 $425.9K +1975.5% -15.4%
Revenue (ASC 606) September 30, 2025 $425.9K +1975.5% -15.4%
Net Income September 30, 2025 -$1.43M +50.3% +24.2%
Diluted EPS September 30, 2025 -$0.83 +79.9% +46.8%
Total Assets September 30, 2025 $3.30M +35.1% -11.3%
Cash and Equivalents March 31, 2022 $594.7K -23.2%
Stockholders Equity September 30, 2025 -$3.98M +2.1% -6.4%
R&D Expense September 30, 2025 $228.0K -31.3% -12.3%
Operating Income September 30, 2025 -$1.47M -3.6% +20.9%
Gross Profit September 30, 2025 $254.5K +1523.0% -15.9%
Shares Outstanding September 30, 2025 1.78M -91.5% +20.1%
  • Longevity Health Holdings, Inc. reported Total Revenue of $1.91 million for fiscal year 2025.
  • Longevity Health Holdings, Inc. showed an increase of +3701.4% in Total Revenue compared to the prior fiscal year.
  • Longevity Health Holdings, Inc. reported Revenue (ASC 606) of $1.91 million for fiscal year 2025.
  • Longevity Health Holdings, Inc. showed an increase of +3701.4% in Revenue (ASC 606) compared to the prior fiscal year.
  • Longevity Health Holdings, Inc. reported Net Income of -$6.91 million for fiscal year 2025.
  • Longevity Health Holdings, Inc. showed an increase of +33.4% in Net Income compared to the prior fiscal year.
  • Longevity Health Holdings, Inc. reported Diluted EPS of $4.83 per share (loss) for fiscal year 2025.
  • Longevity Health Holdings, Inc. showed an increase of +66.8% in Diluted EPS compared to the prior fiscal year.
  • Longevity Health Holdings, Inc. reported Total Assets of $2.37 million for fiscal year 2025.
  • Longevity Health Holdings, Inc. showed an increase of +60.6% in Total Assets compared to the prior fiscal year.
  • Longevity Health Holdings, Inc. reported Cash and Equivalents of $706.7 thousand for fiscal year 2025.
  • Longevity Health Holdings, Inc. showed an increase of +349.8% in Cash and Equivalents compared to the prior fiscal year.
  • Longevity Health Holdings, Inc. reported Stockholders Equity of -$5.87 million for fiscal year 2025.
  • Longevity Health Holdings, Inc. showed a decrease of -24.5% in Stockholders Equity compared to the prior fiscal year.
  • Longevity Health Holdings, Inc. reported R&D Expense of $788.9 thousand for fiscal year 2025.
  • Longevity Health Holdings, Inc. showed a decrease of -25.2% in R&D Expense compared to the prior fiscal year.
  • Longevity Health Holdings, Inc. reported Operating Income of -$7.11 million for fiscal year 2025.
  • Longevity Health Holdings, Inc. showed a decrease of -42.2% in Operating Income compared to the prior fiscal year.
  • Longevity Health Holdings, Inc. reported Gross Profit of $1.09 million for fiscal year 2025.
  • Longevity Health Holdings, Inc. showed an increase of +2390.3% in Gross Profit compared to the prior fiscal year.
  • Longevity Health Holdings, Inc. reported Shares Outstanding of 1.78 million shares for fiscal year 2025.
  • Longevity Health Holdings, Inc. showed an increase of +155.6% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment